Generex To Present Positive Study Data At American Diabetes Association Scientific Sessions 2009.
9:30 am ET 06/04/2009 - GlobeNewswire
WORCESTER, Mass., June 4, 2009 (GLOBE NEWSWIRE) -- "Generex Biotechnology Corporation (Nasdaq:GNBT) (
www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, today announced that data in respect of two of its products will be presented at the American Diabetes Association's (ADA's) 69th Annual Scientific Sessions being held in New Orleans from June 5 to 9.
The annual meeting of the ADA (
www.diabetes.org) is one of the largest scientific meetings for endocrinologists and other health care professionals involved in diabetes research and diabetes care..."
JMHO, but any positive news, plus decent numbers on their 3rd Quarterly Earnings Report due today could make GNBT a big winner this week.
I also like the fact that it is currently trading in the double digits. Not to mention a nice pull back.